Similar articles

• Leishmaniasis: an update of current pharmacotherapy.

  Sundar S, Chakravarty J. Sundar S, et al. Expert Opin Pharmacother. 2013 Jan;14(1):53-63. doi: 10.1517/14656566.2013.755515. Epub 2012 Dec 21. Expert Opin Pharmacother. 2013. PMID: 23256501 Review.
• Recent advances in the treatment of visceral leishmaniasis.

  Davidson RN, Croft SL. Davidson RN, et al. Trans R Soc Trop Med Hyg. 1993 Mar-Apr;87(2):130-1, 141. doi: 10.1016/0035-9203(93)90457-2. Trans R Soc Trop Med Hyg. 1993. PMID: 8393221 Review. No abstract available.
• Treatment of visceral leishmaniasis in 2010: direction from Bihar State, India.

  Murray HW. Murray HW. Future Microbiol. 2010 Sep;5(9):1301-3. doi: 10.2217/fmb.10.92. Future Microbiol. 2010. PMID: 20860475 No abstract available.
• Challenges in the management of visceral leishmaniasis.

  Sundar S, Kumar A. Sundar S, et al. Indian Pediatr. 2005 Jun;42(6):523-6. Indian Pediatr. 2005. PMID: 15995268 No abstract available.
• Eliminating visceral leishmaniasis in South Asia: the road ahead.

  Rijal S, Sundar S, Mondal D, Das P, Alvar J, Boelaert M. Rijal S, et al. BMJ. 2019 Jan 22;364:k5224. doi: 10.1136/bmj.k5224. BMJ. 2019. PMID: 30670453 Free PMC article.